MedTrace Logo

GRACE - Genetic Insights Into Early pRegnancy Loss Using Cell-free fEtal DNA

NCT07639333 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-07-15

No results posted yet for this study

Summary

The aim of this study is to assess the impact of non-invasive prenatal testing right after an early isolated miscarriage on mental health and on the patient's subsequent care in the year following the miscarriage

Conditions

  • Miscarriage in First Trimester
  • Prenatal Genetic Diagnosis

Interventions

GENETIC

Non invasive prenatal test

cell free fetal DNA analysis

Sponsors & Collaborators

  • Rennes University Hospital

    lead OTHER

Principal Investigators

  • Marion Mercier, Md · Rennes University Hospital

  • Vincent LAVOUE, Pr · Rennes University Hospital

  • Sylvie JAILLARD · Rennes University Hospital

  • Erika LAUNAY · Rennes University Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
43 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-30
Primary Completion
2028-03-31
Completion
2029-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07639333 on ClinicalTrials.gov